Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD
Starting soon · Not applicable
Conditions studied: IBD (Inflammatory Bowel Disease), IBD, IBD - Inflammatory Bowel Disease
In brief
This study aims to test the overall hypothesis that the membrane tissue binding capacity of cytokines in the biopsied tissue of patients with Inflammatory Bowel Disease (IBD) is predictive of/strongly correlated to clinical response/outcomes observed. The key questions under investigation are: Aim 1: To assess the fluorescent signal intensity at baseline (control antibody with control biopsy and control antibody with IBD biopsy). Aim 2: To characterize the cellular landscape by surveying surface markers using bar-coded antibodies and performing gene expression profiling on every cell within inflamed tissue of patients with IBD. Aim 3: Develop algorithm using artificial intelligence to predict responders versus non-responders and to further subclassify IBD patients using phenotype data.
Key facts
- Study ID
- NCT07121920
- Run by
- Cook Children's Health Care System
- People needed
- 40
- Starts
- 2025-09-01
- Expected to finish
- 2028-07-01
- Last updated by the study team
- 2025-08-14
Who can join
Age: 2 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients must fall into one of the below categories: (i) with suspected and/or established diagnosis of IBD (ii) patients with IBD on treatment with biologics irrespective of treatment response (iii) patients who are diagnosed with IBD but treatment naïve to biologics. (iv) patients diagnosed with IBS and previous endoscopy results were negative for IBD who will serve as controls
You may not qualify if…
- Those with previous allergy to fluorescein
- Pregnant and breastfeeding patients
Where it is running
- University of Texas at Arlington — Arlington, Texas, United States
- Cook Children's Health Care System — Fort Worth, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.